Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consoldiated) for the quarter and financial year ended 31 March, 2026.